Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
18 citing papers in PubMed, 28 citations in OpenAlex.
Jordina Aviles VerderaFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0009-0007-7575-4244
Lisa StoryFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0001-9328-9592
Megan HallFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0003-2756-6365
Tom FinckFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0002-9229-3183
Alexia EgloffFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0002-2005-8328
Paul T SeedFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0001-7904-7933
Shaihan J MalikFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0001-8925-9032
Mary A RutherfordFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).
Joseph V HajnalFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0002-2690-5495
Raphaël Tomi-TricotFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0002-6149-9154
Jana HutterFrom the Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, 1st Floor South Wing, St Thomas' Hospital, Westminster Bridge Road SE1 7EH London, United Kingdom (J.A.V., L.S., M.H., P.T.S., S.J.M., M.A.R., J.V.H, J.H.); Centre for Medical Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK (J.A.V., L.S., A.E., S.J.M., M.A.R., J.V.H., J.H.); Women's Health, GSTT, London, UK (L.S., M.H., T.F., P.T.S.); Technical University Munich, Munich, Germany (T.F.); MR Research Collaborations, Siemens Healthcare Limited, Camberley, UK (R.T.T.); and Radiological Institute, University Hospital Erlangen, Erlangen, Germany (J.H.).ORCID 0000-0003-3476-3500
St Thomas' Hospital · GBKing's College London · GB
Funding
Department of Health NIHR3016640Medical Research Council MR/T018119/1Medical Research Council MR/W019469/1Wellcome TrustWellcome Trust WT201526/Z/16/Z
6 · The paper itself
Abstract
Background The benefits of using low-field-strength fetal MRI to evaluate antenatal development include reduced image artifacts, increased comfort, larger bore size, and potentially reduced costs, but studies about fetal low-field-strength MRI are lacking. Purpose To evaluate the reliability and feasibility of low-field-strength fetal MRI to assess anatomic and functional measures in pregnant participants using a commercially available 0.55-T MRI scanner and a comprehensive 20-minute protocol. Materials and Methods This prospective study was performed at a large teaching hospital (St Thomas' Hospital; London, England) from May to November 2022 in healthy pregnant participants and participants with pregnancy-related abnormalities using a commercially available 0.55-T MRI scanner. A 20-minute protocol was acquired including anatomic T2-weighted fast-spin-echo, quantitative T2*, and diffusion sequences. Key measures like biparietal diameter, transcerebellar diameter, lung volume, and cervical length were evaluated by two radiologists and an MRI-experienced obstetrician. Functional organ-specific mean values were given. Comparison was performed with existing published values and higher-field MRI using linear regression, interobserver correlation, and Bland-Altman plots. Results A total of 79 fetal MRI examinations were performed (mean gestational age, 29.4 weeks ± 5.5 [SD] [age range, 17.6-39.3 weeks]; maternal age, 34.4 years ± 5.3 [age range, 18.4-45.5 years]) in 47 healthy pregnant participants (control participants) and in 32 participants with pregnancy-related abnormalities. The key anatomic two-dimensional measures for the 47 healthy participants agreed with large cross-sectional 1.5-T and 3-T control studies. The interobserver correlations for the biparietal diameter in the first 40 consecutive scans were 0.96 (95% CI: 0.7, 0.99;
Indexed as
Magnetic Resonance ImagingPlacentaAdolescentAdultCross-Sectional StudiesFeasibility StudiesFemaleFetusHumansMiddle AgedPregnancyProspective StudiesReproducibility of ResultsYoung Adult
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Reliability and Feasibility of Low-Field-Strength Fetal MRI at 0.55 T during Pregnancy. · full record | OpenQuestion